Remission of Endometriosis by Hyperbaric Oxygen Treatment in Rats

article OA: closed CC0 ⤵ 5 in-corpus citations
AI-generated summary by claude@2026-06+body, 2026-06-21

Hyperbaric oxygen treatment for 6 weeks significantly reduced endometriotic implant volume, histopathologic scores, Ki-67 levels, and peritoneal fluid TNF-α in a rat model.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-21 · read from full text

This prospective randomized controlled animal study investigated whether hyperbaric oxygen (HBO) could induce remission of experimentally induced endometriosis in 40 nonpregnant female Wistar-Albino rats. After surgical induction of endometriosis, rats were evaluated at 4 weeks with laparotomy for implant volume measurement and peritoneal fluid collection, then randomized to HBO or control; the HBO group received 2 hours/day for 6 weeks, followed by a final laparotomy with outcomes including implant volume, histopathologic scores, Ki-67 immunohistochemical scores, and peritoneal fluid tumor necrosis factor-α (TNF-α). HBO-treated rats had significantly smaller endometriotic implants (57.4 vs 94.6 mm³), lower histopathologic and Ki-67 scores, and reduced TNF-α levels compared with controls, indicating significant remission. The main limitation stated by design is that this was an experimentally induced rat model, which may not directly translate to human disease. This paper is centrally about endometriosis — it tests hyperbaric oxygen treatment for remission of experimentally induced endometriosis in rats.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

We designed this prospective, randomized controlled animal study to determine the effects of hyperbaric oxygen (HBO) on experimentally induced endometriosis in a rat model. Surgical induction of endometriosis was performed in 40, nonpregnant, female, Wistar-Albino rats at the Experimental Medicine Research Center of Istanbul University (DETAE). Four weeks later, the first and second laparotomies for volume measurement and peritoneal fluid (PF) collection were performed, and the rats were divided randomly into the study and control groups. The study group was exposed to HBO treatment for 6 weeks. Then, a third laparotomy was performed on all of the rats. The volume, histopathologic scores, Ki-67 labeling of the endometriotic implants, and the levels of tumor necrosis factor-α (TNF-α) in the PF were measured. The mean volume of the endometriotic implants in the study group was significantly lower than that of the control group at the end of the study (57.4 ± 12.5 vs 94.6 ± 17.2 mm(3)). The mean histopathological scores (1.60 ± 0.50 vs 2.42 ± 0.51), Ki-67 immunohistochemical scores (1.50 ± 0.51 vs 2.37 ± 0.49) of the endometriotic implants, and the TNF-α levels (5.33 ± 1.02 vs 8.16 ± 1.76 pg/mL) were significantly lower in the study group than in the control group. Hyperbaric oxygen treatment for 2 hours a day for 6 weeks resulted in significant remission of endometriosis in rats.
Full text 9,713 characters · extracted from oa-doi-fallback · 2 sections · click to expand

Abstract

We designed this prospective, randomized controlled animal study to determine the effects of hyperbaric oxygen (HBO) on experimentally induced endometriosis in a rat model. Surgical induction of endometriosis was performed in 40, nonpregnant, female, Wistar-Albino rats at the Experimental Medicine Research Center of Istanbul University (DETAE). Four weeks later, the first and second laparotomies for volume measurement and peritoneal fluid (PF) collection were performed, and the rats were divided randomly into the study and control groups. The study group was exposed to HBO treatment for 6 weeks. Then, a third laparotomy was performed on all of the rats. The volume, histopathologic scores, Ki-67 labeling of the endometriotic implants, and the levels of tumor necrosis factor-α (TNF-α) in the PF were measured. The mean volume of the endometriotic implants in the study group was significantly lower than that of the control group at the end of the study (57.4 ± 12.5 vs 94.6 ± 17.2 mm3). The mean histopathological scores (1.60 ± 0.50 vs 2.42 ± 0.51), Ki-67 immunohistochemical scores (1.50 ± 0.51 vs 2.37 ± 0.49) of the endometriotic implants, and the TNF-α levels (5.33 ± 1.02 vs 8.16 ± 1.76 pg/mL) were significantly lower in the study group than in the control group. Hyperbaric oxygen treatment for 2 hours a day for 6 weeks resulted in significant remission of endometriosis in rats. Similar content being viewed by others

References

Benson RM, Minter LM, Osborne BA, Granowitz EV. Hyperbaric oxygen inhibits stimulus-induced proinflammatory cytokine synthesis by human blood-derived monocyte-macrophages. Clin Exp Immunol. 2003;134(1):57–62 Fildissis G, Venetsanou K, Myrianthefs P, Karatzas S, Zidianakis V, Baltopoulos G. Whole blood pro-inflammatory cytokines and adhesion molecules post-lipopolysaccharides exposure in hyperbaric conditions. Eur Cytokine Netw. 2004;15(3):217–221 Brenner I, Shepard RJ, Shek PN. Immune function in hyperbaric environments, diving, and decompression. Undersea Hyper Med. 1999;26(1):27–39 Murphy SA, Hyams JS, Fisher AB, Root RK. Effects of oxygen exposure on in vitro function of pulmonary alveolar macrophages. J Clin Invest. 1975;56(2):503–511 Inamoto Y, Okuno F, Saito K, et al. Effect of hyperbaric oxygenation on macrophage function in mice. Biochem Biophys Res Comm. 1991;179(2):886–891 Lahat N, Bitterman H, Yaniv N, Kinarty A, Bitterman N. Exposure to hyperbaric oxygen induces tumour necrosis factor-alpha (TNF-a) secretion from rat macrophages. Clin Exp Immunol. 1995;102(3):655–659 Yang Z, Nandi J, Wang J, et al. Hyperbaric oxygenation ameliorates indomethacin-induced enteropathy in rats by modulating TNF-alpha and IL-1beta production. Dig Dis Sci. 2006;51(8):1426–1433 Wu MY, Ho HN. The role of cytokines in endometriosis. Am J Reprod Immunol. 2003;49(3):285–296 Ethridge RT, Hashimoto K, Chung DH, Ehlers RA, Rajaraman S, Evers BM. Selective inhibition of NF-ΚB attenuates the severity of cerulein-induced acute pancreatitis. J Am Coll Surg. 2002;195(4):497–505 Gukovsky I, Gukovskaya AS, Blinman TA, Zaninovic V, Pandol SJ. Early NF kappa B activation is associated with hormone-induced pancreatitis. Am J Physiol. 1998;275(6 pt 1):1402–1414 Kim H, Seo JY, Roh KH, Lim JW, Kim KH. Suppression of NF-ΚB activation and cytokine production by N-acetylcysteine in pancreatic acinar cells. Free Rad Biol Med. 2000;29(7):674–683 Carswell EA, Old LJ, Kassel RL, Gren S, Fiore N, Williamson B. An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA. 1975;72(9):3666–3670 Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 1984;312(5996):724–729 Locksley RM, Killen N, Lenardo MJ. The TNF and TNF receptor superfamilies: integrating mammalian biology. Cell. 2001;104(4):487–501 Chen HL, Yang YP, Hu XL, Yelavarthi KK, Fishback JL, Hunt JC. Tumor necrosis factor alpha mRNA and protein are present in human placental and uterine cells at early and late stages of gestation. Am J Pathol. 1991;139(2):327–335 Jokhi PP, King A, Loke YW. Cytokine production and cytokine receptor expression by cells of the human first trimester placental-uterine interface. Cytokine. 1997;9(2):126–137 Bornstein SR, Rutkowski H, Vrezas I. Cytokines and steroidogenesis. Mol Cell Endocrinol. 2004;215(1–2):135–141 Wuttke W, Jarry H, Pitzel L, Knoke I, Spiess S. Luteotrophic and luteolytic actions of ovarian peptides. Hum Reprod. 1993;8(suppl 2):141–146 Terranova PF, Rice VM. Review: cytokine involvement in ovarian processes. Am J Reprod Immunol. 1997;37(1):50–63 Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertil Steril. 1985;44(5):684–694 Keenan JA, Williams-Boyce PK, Massey PJ, Chen TT, Caudle MR. Bukovsky A regression of endometrial explants in a rat model of endometriosis treated with the immune modulators loxoribine and levamisole. Fertil Steril. 1999;72(1):135–141 Hunter S, Langemo DK, Anderson J, Hanson D, Thompson P. Hyperbaric oxygen therapy for chronic wounds. Adv Skin Wound Care. 2010;23(3):116–1169 Van den Blink B, van der Kleij AJ, Versteeg HH, Peppelenbosch MP. Immunomodulatory effect of oxygen and pressure. Comp Biochem Physiol Physiol. 2002;132(1):193–197 Luongo C, Imperatore F, Cuzzocrea S, et al. Effects of hyperbaric oxygen exposure on a zymosan-induced shock model. Crit Care Med. 1998;26(12):1972–1976 Yamashita M, Yamashita M. Hyperbaric oxygen treatment attenuates cytokine induction after massive hemorrhage. Am J Physiol Endocrinol Metab. 2000;278(5):811–816 Yang Z, Bosco G, Montante A, Ou X, Camporesi EM. Hyperbaric 02 reduces intestinal schemia-reperfusion-induced TNF-a production and lung neutrophil sequestration. Eur J Appl Physiol. 2001;85(1–2):96–103 Yamauchi N, Harada T, Taniguchi F, Yoshida S, Iwabe T, Terakawa N. Tumor necrosis factor-alpha induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-kappaB and mitogen-activated protein kinase pathways. Fertil Steril. 2004;82(suppl 3):1023–1028 Yu X, Li YG, He XW, et al. Hyperbaric oxygen reduces inflammatory response in acute pancreatitis by inhibiting NF- kappaB activation. Eur Surg Res. 2009;42(2):130–135 Yu X, Zhang SD, Hang TQ. The change of pancreatic acinar cell function in murine acute necrotizing pancreatitis. Chin J Gen Surg. 2000;15(5):280–282 Wang F, He YL, Peng DX, Liu MB. Expressions of nuclear factor-kappaB and intercellular adhesion molecule-1 in endometriosis. Di Yi Jun Yi Da Xue Xue Bao. 2005;25(6):703–705 Horie S, Harada T, Mitsunari M, Taniguchi F, Iwabe T, Terakawa N. Progesterone and progestational compounds attenuate tumor necrosis factor alpha-induced interleukin-8 production via nuclear factor kappa B inactivation in endometriotic stromal cells. Fertil Steril. 2005;83(5):1530–1535 Wieser F, Vigne JL, Ryan I, Hornung D, Djalali S, Taylor RN. Sulindac suppresses nuclear factor-kappaB activation and RANTES gene and protein expression in endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metabol. 2005;90(12):6441–6447 Kuroda K, Kitade M, Kikuchi I, et al. Peritoneal vascular density assessment using narrow-band imaging and vascular analysis software, and cytokine analysis in women with and without endometriosis. J Minim Invasive Gynecol. 2009;3(1):704–710 Kyama CM, Overbergh L, Mihalyi A, et al. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis. Fertil Steril. 2008;89(2):301–310 Chen Q, Zhou W, Pu D, Li Z, Huang Q, Chen Q. The inhibitory effect of 15-R-LXA4 on experimental endometriosis. Eur J Obstet Gynecol Reprod Biol. 2009;145(2):200–204 Chen QH, Zhou WD, Su ZY, Huang QS, Jiang JN, Chen QX. Change of proinflammatory cytokines follows certain patterns after induction of endometriosis in a mouse model. Fertil Steril. 2009;31(5):217–224 Gogacz M, Bogusiewicz M, Putowski L, et al. Expression of tumor necrosis factor-alpha (TNF-alpha) on peritoneal fluid mononuclear cells in women with endometriosis. Ginekol Pol. 2008;79(1):31–35 Kim HO, Yang KM, Kang IS, et al. Expression of CD44s, vascular endothelial growth factor, matrix metalloproteinase-2 and Ki-67 in peritoneal, rectovaginal and ovarian endometriosis. J Reprod Med. 2007;52(3):207–213 Park JS, Lee JH, Kim M, Chang HJ, Hwang KJ, Chang KH. Endometrium from women with endometriosis shows increased proliferation activity. Fertil Steril. 2009;92(4):1246–1249 Celik O, Hascalik S, Elter K, Tagluk ME, Gurates B, Aydin NE. Combating endometriosis by blocking proteasome and nuclear factor-kappaB pathways. Hum Reprod. 2008;23(11):2458–2465 Cimşit M, Uzun G, Yildiz S. Hyperbaric oxygen therapy as an anti-infective agent. Expert Rev Anti Infect Ther. 2009;7(8):1015–1026 Bessereau J, Tabah A, Genotelle N, Français A, Coulange M, Annane D. Middle-ear barotrauma after hyperbaric oxygen therapy. Undersea Hyperb Med. 2010;37(4):203–208 Lee CH, Chen WC, Wu CI, Hsia TC. Tension pneumocephalus: a rare complication after hyperbaric oxygen therapy. Am J Emerg Med. 2009;27(2):251–257 Rivalland G, Mitchell SJ, van Schalkwyk JM. Pulmonary barotrauma and cerebral arterial gas embolism during hyperbaric oxygen therapy. Aviat Space Environ Med. 2010;81(9):888–890 Author information Authors and Affiliations Corresponding author Rights and permissions About this article Cite this article Aydin, Y., Atis, A., Uludag, S. et al. Remission of Endometriosis by Hyperbaric Oxygen Treatment in Rats. Reprod. Sci. 18, 941–947 (2011). https://doi.org/10.1177/1933719111400635 Published: Issue date: DOI: https://doi.org/10.1177/1933719111400635

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

MeSH descriptors

Endometriosis Hyperbaric Oxygenation Oxygen Animals Endometriosis Endometriosis Female Hyperbaric Oxygenation Immunohistochemistry Ki-67 Antigen Ki-67 Antigen Oxygen Prospective Studies Rats Rats, Wistar Tumor Necrosis Factor-alpha Tumor Necrosis Factor-alpha

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (45)

Cited by (5)

Source provenance

europepmc
last seen: 2026-08-01T06:07:04.264727+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:16:29.858026+00:00
License: CC0 · commercial use OK